Cargando…
MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment
To overcome the lack of effective pharmacological treatments for high-risk neuroblastoma (HR-NB), the development of novel in vitro and in vivo models that better recapitulate the disease is required. Here, we used an in vitro multiclonal cell model encompassing NB cell differentiation stages, to id...
Autores principales: | Garbati, Patrizia, Barbieri, Raffaella, Cangelosi, Davide, Zanon, Carlo, Costa, Delfina, Eva, Alessandra, Thellung, Stefano, Calderoni, Matilde, Baldini, Francesca, Tonini, Gian Paolo, Modesto, Paola, Florio, Tullio, Pagano, Aldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692293/ https://www.ncbi.nlm.nih.gov/pubmed/33153038 http://dx.doi.org/10.3390/biomedicines8110471 |
Ejemplares similares
-
Efficacy of a Three Drug-Based Therapy for Neuroblastoma in Mice
por: Garbati, Patrizia, et al.
Publicado: (2021) -
Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment
por: Brizzolara, Antonella, et al.
Publicado: (2020) -
An Overview of Long Non-Coding (lnc)RNAs in Neuroblastoma
por: Baldini, Francesca, et al.
Publicado: (2021) -
Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA
por: Vella, Serena, et al.
Publicado: (2015) -
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies
por: Bajetto, Adriana, et al.
Publicado: (2020)